Previous close | 0.9170 |
Open | 0.9170 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's range | 0.8865 - 0.9295 |
52-week range | 0.7560 - 1.8700 |
Volume | |
Avg. volume | 212,543 |
Market cap | 27.381M |
Beta (5Y monthly) | 3.00 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.0910 |
Earnings date | 29 Apr 2022 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 1.70 |
PARIS & BOULDER, Colo., May 04, 2022--Regulatory News: SpineGuard (FR0011464452 – ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) sensing technology to secure and streamline the placement of bone implants, announced that research teams presented three articles at the CRAS conference on April 25th and 26th in Naples, Italy. They report the progress made with the robotic application of DSG.
PARIS & BOULDER, Colo., May 02, 2022--Regulatory News: SpineGuard (Paris:ALSGD) (FR0011464452 – ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) sensing technology to secure and streamline the placement of bone implants, announces that its Annual Shareholders’ Meeting will be held on Wednesday June 8, 2022 at 10:00am CEST at the offices of the law firm Ashurst located in Paris, at 18, Square Edouard VII, 75009 (France) and inform on its voting modalities.
PARIS & BOULDER, Colo., April 28, 2022--Regulatory News: SpineGuard (FR0011464452 – ALSGD) (Paris:ALSGD), an innovative company that deploys its DSG (Dynamic Surgical Guidance) sensing technology to secure and streamline the placement of bone implants, announced today its full-year 2021 financial results, as approved by the Board of Directors on April 28, 2022 and its first quarter 2022 sales.